ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A. Chang (Brisbane (QLD), Australia)
Source: International Congress 2022 – ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Chang (Brisbane (QLD), Australia). ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials. International Congress 2022 – ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|